Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women

This study has been completed.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: May 18, 2001
Last updated: October 31, 2012
Last verified: October 2012